LMNL 6326
Alternative Names: LMNL-6326Latest Information Update: 11 Aug 2023
At a glance
- Originator Liminal BioSciences
- Class Anti-inflammatories; Antiasthmatics; Small molecules
- Mechanism of Action Eicosanoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Asthma; Atopic dermatitis
Highest Development Phases
- Preclinical Asthma; Atopic dermatitis